| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |